AIDS Therapies

Pokeweed Antiviral Protein Shows Promise

Published in AIDS Weekly, December 27th, 1999

Pokeweed antiviral protein (PAP), a natural product isolated from the pokeweed plant, shows great potential as a new anti-HIV drug, researchers from the Hughes Institute, St. Paul, Minnesota, report.

In a clinical study, nine out of nine patients were treated with a single dose of this agent and tolerated the treatment with no side effects. Most notably, six out of six patients evaluated for a response of their disease showed reduction of their viral burden. These patients also showed a 3-to-5 fold enhancement of their immune function represented by their natural killer cells and B-cells.

The results of this study are reported by Hughes Institute...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-12-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry